These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23802311)

  • 21. Intracardiac entrapped and pulmonary embolism developing during oral contraceptive therapy in a young woman.
    Erkut B; Ates A; Arslan S
    J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):297-8. PubMed ID: 20019620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
    Sidney S; Cheetham TC; Connell FA; Ouellet-Hellstrom R; Graham DJ; Davis D; Sorel M; Quesenberry CP; Cooper WO
    Contraception; 2013 Jan; 87(1):93-100. PubMed ID: 23083525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond politics: new medical concerns for contraceptive users.
    Wallis L
    Am J Nurs; 2012 Jul; 112(7):19. PubMed ID: 22739598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombosis--adverse effect of drugs].
    Ota S; Yamada N; Nakano T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():450-4. PubMed ID: 18074580
    [No Abstract]   [Full Text] [Related]  

  • 25. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.
    Weill A; Dalichampt M; Raguideau F; Ricordeau P; Blotière PO; Rudant J; Alla F; Zureik M
    BMJ; 2016 May; 353():i2002. PubMed ID: 27164970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
    Martínez F; Ramírez I; Pérez-Campos E; Latorre K; Lete I
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):7-29. PubMed ID: 22239262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose oral contraceptive-induced acute myocardial infarction.
    Aslan AN; Süygün H; Sivri S; Keleş T
    Eur J Contracept Reprod Health Care; 2016 Dec; 21(6):499-501. PubMed ID: 27608962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R;
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral contraceptives: cardiovascular complications and additional risk factors (author's transl)].
    Herzog C
    Schweiz Rundsch Med Prax; 1979 Oct; 68(41):1321-9. PubMed ID: 394143
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral contraceptives and thrombosis. From risk estimates to health impact.
    Lidegaard O; Bygdeman M; Milsom I; Nesheim BI; Skjeldestad FE; Toivonen J
    Acta Obstet Gynecol Scand; 1999 Feb; 78(2):142-9. PubMed ID: 10023878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
    Han L; Jensen JT
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.
    Peragallo Urrutia R; Coeytaux RR; McBroom AJ; Gierisch JM; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; Hasselblad V; Sanders GD; Myers ER
    Obstet Gynecol; 2013 Aug; 122(2 Pt 1):380-389. PubMed ID: 23969809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary embolism.
    Robinson G
    Lancet; 2004 Jul 17-23; 364(9430):244. PubMed ID: 15262095
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
    Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature].
    Herzog C; Mall-Haefeli M
    Ther Ggw; 1979 Oct; 118(10):1550-74. PubMed ID: 386549
    [No Abstract]   [Full Text] [Related]  

  • 38. Thromboembolism associated with the new contraceptive Yasmin.
    van Grootheest K; Vrieling T
    BMJ; 2003 Feb; 326(7383):257. PubMed ID: 12560278
    [No Abstract]   [Full Text] [Related]  

  • 39. Drospirenone Litigation: Does the Punishment Fit the Crime?
    Batur P; Casey PM
    J Womens Health (Larchmt); 2017 Feb; 26(2):99-102. PubMed ID: 27854556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal right ventricular infarction in association with contraceptive pills, without coronary disease.
    Partanen J; Syvänne M
    Arch Intern Med; 1993 Mar; 153(5):665. PubMed ID: 8439230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.